Skip to content

Clinical trials

Phase 2/3 Tuberculosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis Phase: Phase 2/3 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20071
20132
20142
20151
20161
20171
20181
20191
20203
20212
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status5
Recruiting3
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Cape Town3
All India Institute of Medical Sciences1
Centers for Disease Control and Prevention1
Dartmouth-Hitchcock Medical Center1
French National Agency for Research on AIDS and Viral Hepatitis1
Fundació Institut Germans Trias i Pujol1
Global Alliance for TB Drug Development1
Hasanuddin University1
Hospital Universitario 12 de Octubre1
International Maternal Pediatric Adolescent AIDS Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis23
Acquired Immunodeficiency Syndrome4
HIV Infections4
Tuberculosis, Pulmonary4
Tuberculosis, Multidrug-Resistant3
Latent Tuberculosis2
Arachnoiditis1
Chemical and Drug Induced Liver Injury1
Cough1
Cytomegalovirus Infections1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.